Wednesday, July 08, 2020
Gerri Detweiler joins Jim Blasingame to report on the challenges some small businesses are having getting loans, and differentiating between the different lending sources.
Gerri Detweiler joins Jim Blasingame to report on the SBA’s Emergency Income Disaster Loan program, how it’s different from PPP, and how it works.
Doug Tatum joins Jim Blasingame to report on how the global business process is being altered permanently by the pandemic, especially how it is changing supply chain practices, and the damage done to the China brand.
Doug Tatum joins Jim Blasingame to report on a new college course he’s working on that will introduce to students why the concept of profit is about abundance, and the prime source of funds for the non-profit sector.
Doug Tatum joins Jim Blasingame to report on how the current pandemic conditions have impacted the availability of entrepreneurs to get funding for growth, including why getting big isn’t for every entrepreneur.
Jessica Moser joins Jim Blasingame to report on the most recent MetLife/U.S. Chamber Index that shows the negative impact of the pandemic is lessening for Main Street businesses.
Jessica Moser joins Jim Blasingame to report on the MetLife/U.S. Chamber Index that shows small businesses are making a marked shift toward digital, as well as learning how to manage the next pandemic-like disruption.
Dr. Marilyn Singleton joins Jim Blasingame to offer her perspective on why, warts and all, America is still the land of opportunity for everyone, but only if we shift to focusing on making the future better, without blame about the past.
Dr. Marilyn Singleton joins Jim Blasingame to offer her perspective as a “Black Boomer” woman on the negative impact of the Black Lives Matter organization, which has a stated focus on efforts that do not represent what’s best for the future of America.
Dr. Marilyn Singleton joins Jim Blasingame to report as a medical professional that we’re succeeding against the COVID-19 disease because increased incidence is a product of better testing, while hospitalizations and deaths from the disease are down.